ANTIBODIES TO LIVER-SPECIFIC PROTEIN PREDICT OUTCOME OF TREATMENT WITHDRAWAL IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS
- 1 October 1984
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 324 (8409) , 954-956
- https://doi.org/10.1016/s0140-6736(84)91167-x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- ANTIGEN SPECIFIC SUPPRESSOR CELL FUNCTION IN AUTOIMMUNE CHRONIC ACTIVE HEPATITISThe Lancet, 1984
- Relapse Following Treatment Withdrawal in Patients with Autoimmune Chronic Active HepatitisHepatology, 1983
- Hepatocyte Membrane–Bound Igg and Circulating Liver–Specific Autoantibodies in Chronic Liver Disease: Relation to Hepatitis B Virus Serum Markers and Liver HistologyHepatology, 1983
- Effect of Corticosteroids on Suppressor-Cell Activity in Autoimmune and Viral Chronic Active HepatitisNew England Journal of Medicine, 1982
- The nature and prognostic significance of serial amino acid determinations in severe chronic active liver diseaseGastroenterology, 1981
- Corticosteroid-Treated Chronic Active Hepatitis in RemissionNew England Journal of Medicine, 1981
- Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remissionGastroenterology, 1980
- Detection of Antibodies Directed against a Liver-Specific Membrane Lipoprotein in Patients with Acute and Chronic Active HepatitisNew England Journal of Medicine, 1978
- Assessment of the (14C) aminopyrine breath test in liver disease.Gut, 1978
- Assessment of Activity in Chronic Active Liver DiseaseNew England Journal of Medicine, 1974